Actions

Extra: Difference between revisions

From haematologyetc.co.uk

No edit summary
No edit summary
Line 1: Line 1:
:CD23 is a broadly expressed molecule whose impotance lies in its value in distinguishing between CLL (consistent expression) and MCL (infrequent expression).
CD7', ' *CD7 may be regarded as a pan t-cell marker that is useful for identifying t cells from very early stages of maturation however the high frequency of aberrant expression of CD7 means that caution is required in itsu8e28099 interpretation *variation of expression of CD7 by mature t cells can have diagnostic value in particular there is frequentl loss of CD7 expression in many cases of su8c3a9zary syndrome details CD7 is a transmembrane protein that supports t-cell b-cell interactions during lymphoid development. expression is acquired during thymic development of t cells appearing before other t-lineage markers and is retained by mature t cells. * very consistent expression by t-all from an early pro-t stage of maturation. however expression is seen frequently also in aml 30 and may occur in b-all * loss of CD7 expression occurs in mycosis fungoides and su8c3a9zary syndrome and can contribute to diagnosis * quantitative expression of CD7 is seen with high levels of expression in t-all and t-pll but lower in atll and lgl disorders
:However, CD23 is not a CLL-specific marker, and is also expressed on other haematological and lymphoma cell types.  
 
normal expression and function  
 
CD23 is a low-affinity receptor for IgE that is involved in antigen capture and presentation. It affects B-cell growth and differentiation and the activation of monocytes. It is expressed on activated B-cells, but also platelets eosinophils activated macrophages and follicular dendritic cells
 
 
other relevant information 
 
When CD23 is expressed by MCL the cases may have a more indolent course and an improved outcome.
 
 
diagnostic role 
*CD23 is most frequently used to distinguish between CLL and MCL but this difference is not absolute: CD23 is expressed by the vast majority (90% of typical CLL patients), and is generally absent in MCL although it is detected in around 10% of cases where its expression may be bright.  
*CD23 may also be expressed by other B-lymphoproliferative disorders although at lower frequency:including lymphoplasmacytic lymphoma, marginal zone lymphoma or follicular lymphoma.
 
 
summary tables 
 
1. expression by acute leukaemias and by haematogones file rare.png  pro-b all link flow cytometry key file rareu82epng  early pre-b all  link flow cytometry key file rareu82epng  pre-b all  link flow cytometry key file rareu82epng  early b all  link flow cytometry key file rareu82epng  pro-t all  link flow cytometry key file rareu82epng  mature-t all link flow cytometry key file possu82epng  aml  link flow cytometry key file rareu82epng  haemato-gones  link flow cytometry key  *may be expressed in aml with monocytic differentiation 
 
2. expression by b-lymphoproliferative disorders file hiu82epng frame  cll  link flow cytometry key file rareu82epng  pll  link flow cytometry key file possu82epng  mcl  link flow cytometry key file modu82epng  fl  link flow cytometry key file possu82epng  hcl  link flow cytometry key file possu82epng  hclv  link flow cytometry key file rareu82epng  mzl  link flow cytometry key file rareu82epng  lpl  link flow cytometry key file rareu82epng  pcs  link flow cytometry

Revision as of 10:33, 13 May 2023

CD7', ' *CD7 may be regarded as a pan t-cell marker that is useful for identifying t cells from very early stages of maturation however the high frequency of aberrant expression of CD7 means that caution is required in itsu8e28099 interpretation *variation of expression of CD7 by mature t cells can have diagnostic value in particular there is frequentl loss of CD7 expression in many cases of su8c3a9zary syndrome details CD7 is a transmembrane protein that supports t-cell b-cell interactions during lymphoid development. expression is acquired during thymic development of t cells appearing before other t-lineage markers and is retained by mature t cells. * very consistent expression by t-all from an early pro-t stage of maturation. however expression is seen frequently also in aml 30 and may occur in b-all * loss of CD7 expression occurs in mycosis fungoides and su8c3a9zary syndrome and can contribute to diagnosis * quantitative expression of CD7 is seen with high levels of expression in t-all and t-pll but lower in atll and lgl disorders